Classys (214150 KS): Stellar 3Q Result; 2025 Guidance Reaffirmed; Brazil Is Set to Recover from 4Q
Classys reports 40% revenue growth in 3Q25. Despite controlled sales in Brazil, export grew 32% YoY, indicating multi-regional growth. 4Q25...
360 Views
Classys (214150 KQ Nov 11, 2025) - V-Shape Rebound Begins
Full-year guidance intact despite weak Brazil; 4Q25 revenue growth expected to exceed 15% QoQ. Quadessy and Reepot both strong, steady installments...
131 Views
Classys (214150 KQ/Buy)Targeting Brazil with a Proven M&A Playbook
For 3Q25, Classys reported in-line revenue of W83bn (+40% YoY) and below-consensus operating profit of W37.6bn (+30% YoY; OP margin of 45.3%).
131 Views
Primer: Classys (214150 KS) - Nov 2025
Classys is a high-growth medical aesthetics company poised for significant global expansion, driven by its flagship 'Ultraformer' (HIFU) and...
145 Views
Classys (214150 KS): Equipment Sale Boosts 2Q Result; New Device Approval to Drive 2H Performance
Classys reports 2Q25 result with record high sales and operating profit. The company reaffirmed 2025 sales guidance of KRW340–360B, up 39–48% YoY....
257 Views